Sun Pharmaceutical Industries Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sun Pharmaceutical Industries Limited generated cash of $121,349,800,000, which is more than the previous year. Cash used in financing activities reached the amount of -$67,101,600,000 last year. Net change in cash is therefore $46,619,200,000.
Cash Flow
| 2010 | 7.93B | -2.25B | -3.46B |
|---|---|---|---|
| 2011 | 23.89B | -21.48B | -7.74B |
| 2012 | 23.48B | -8.64B | -5.44B |
| 2016 | 67.69B | -44.54B | -19.24B |
| 2018 | 39.07B | -33.70B | -15.39B |
| 2020 | 65.54B | -25.88B | -57.15B |
| 2021 | 61.70B | 5.36B | -59.80B |
| 2023 | 49.59B | -79.43B | 23.76B |
| 2024 | 121.34B | -6.90B | -67.10B |
SUNPHARMA.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 46.23B | 45.08B | 56.76B | 70.62B | 86.42B | 72.85B | 8.10B | 6.72B | 4.51B |
Operating activities | |||||||||
Net income | 95.76B | 94.08B | 27.99B | 50.09B | 34.78B | 67.65B | 25.87B | 18.16B | 13.46B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 25.56B | 25.29B | 20.79B | 20.52B | 14.99B | 10.13B | 2.91B | 2.04B | 1.53B |
Stock-based compensation expense | 0 | 0 | 0 | 0 | -1M | 98.8M | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | -1M | 98.8M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 3.52B | -9.53B | 937.3M | -3.74B | -7.73B | -18.10B | 0 | 0 | 0 |
Inventories | 5.98B | -12.02B | -10.80B | 2.56B | -40M | -1.66B | -5.97B | -712.6M | -981.5M |
Accounts payable | 2.49B | 11.82B | 3.81B | -1.36B | 3.83B | 3.62B | 0 | 0 | 0 |
Cash generated by operating activities | 121.34B | 49.59B | 61.70B | 65.54B | 39.07B | 67.69B | 23.48B | 23.89B | 7.93B |
Investing activities | |||||||||
Purchases Of Investments | -306.78B | -226.89B | -188.23B | -344.14B | -422.67B | -466.91B | -131.75B | -123.19B | -165.55B |
Investments In Property Plant And Equipment | -22.01B | -20.85B | -11.70B | -15.42B | -19.60B | -33.82B | -7.12B | -4.45B | -2.84B |
Acquisitions Net | -2.29B | -46.85B | -616M | 8.05B | -855M | -10.71B | 0 | 0 | 0 |
Cash generated by investing activities | -6.90B | -79.43B | 5.36B | -25.88B | -33.70B | -44.54B | -8.64B | -21.48B | -2.25B |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 62.59B | 0 | 9.1M | 91.3M | 0 | 0 | 0 |
Payments for dividends | -28.98B | -25.18B | -15.59B | -16.62B | -7.98B | -7.21B | -3.52B | -2.84B | -2.84B |
Repurchases of common stock | -773.9M | 0 | -1.85B | -2.12B | -6.75B | -469.5M | -14.3M | 0 | 0 |
Repayments of term debt | -33.89B | 51.29B | -109.19B | -31.22B | -5.74B | -7.81B | -521.6M | -3.78B | -383M |
Cash used in financing activities | -67.10B | 23.76B | -59.80B | -57.15B | -15.39B | -19.24B | -5.44B | -7.74B | -3.46B |
Net Change In Cash | 46.61B | 1.15B | 5.96B | -13.85B | -7.35B | 8.34B | 9.42B | 135.8M | 2.20B |
Cash at end of period | 92.85B | 46.23B | 62.73B | 56.76B | 79.06B | 81.19B | 17.52B | 6.85B | 6.72B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |